Here are relevant reports on : hospital-bed-mattress-market
-
Medical Bed Market by Usage (Acute Care, Long Term Care, Psychiatric Care, Maternity), Application (Intensive Care, Non Intensive), Type (Electric Beds, Semi Electric Bed, Manual Bed), End User (Hospital, Home Care, Elderly Care) & Geography - Global Forecast to 2022
Medical bed market is projected to grow at a CAGR of 5.6%. Factors such as increasing investments in healthcare infrastructural development, technological innovations in ICU beds, increasing number of beds in private hospitals, and increasing volume of chronic care patients are expected to drive the growth of the medical beds market in the coming years. On the other hand, the declining number of beds in public hospitals may limit market growth to a certain extent.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Gasification Market by Gasifier Type (Moving/Fixed Bed, Fluidized Bed, Entrained & Others), by Feedstock (Biomass/Waste, Coal, Natural Gas & Petroleum), by Application (Chemicals, Liquid Fuels, Power & Gas Fuels) and Geography - Global Trends and Forecasts (2014 - 2019)
Gasification has reliably gained a good market in the past few decades, as there is a rise in chemical, energy, and natural gas demand all over the world. Gasification is a thermochemical process, thus there is a considerable interest in routes to liquid biofuels involving gasification as a result of the potential for routes to have low costs, high efficiency, and high well-to-wheel greenhouse savings. The improvement in characteristics of current fuels has taken the production of fuels upwards compared to traditional biofuels. This has become a substitute for clean energy supply with increased acceptance.
- Published: June 2014
- Price: $ 4950
- TOC Available:
-
Hospital Capacity Management Solutions Market Size, Growth by Product (Asset, Bed Management, Nurse Scheduling, Patient Flow Management), Component (Software, Integrated, Services), Delivery Mode (On-premise, Cloud), End User (Hospitals, ASC) & Region - Global Forecast to 2026
The global hospital capacity management solutions market in terms of revenue was estimated to be worth USD 3.2 billion in 2021 and is poised to reach USD 7.0 billion by 2026, growing at a CAGR of 17.1% from 2021 to 2026. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Ligation Devices Market by Product (Hand-held Instruments, Accessories), Procedure (Minimally Invasive & Open Surgery), Application (Gynaecology, GIT, Cardiothoracic, Urology), End User (Hospital, Nursing Homes) - Global Forecast to 2024
The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Some of the major players in this market include Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecule-targeted Microbubbles, Software], Application (Diagnostic, Therapeutic, CVDs, Liver, Kidney, Oncology), End User (Hospital, Clinics, ASCs) & Region - Global Forecast to 2028
The global contrast enhanced ultrasound market, valued at US$1.4 billion in 2022, stood at US$1.6 billion in 2023 and is projected to advance at a resilient CAGR of 6.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. The rising use of contrast agents, increasing partnerships and collaborations, and the introduction of novel technologies are expected to drive the market during the forecast period.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Spirometer Market by Product (Device, Consumables and Accessories, Software), Mechanism (Flow Sensor, Peak Flow Meter), Application (COPD, Asthma), End User (Hospital, Clinical Laboratory, Homecare, Industrial Setting) & Region - Global Forecast to 2025
The global spirometer market growth is primed to transition from $799 million in 2020 to $1.3 billion by 2025, showcasing a strong CAGR of 11.1%. Growth in this market is largely driven by the rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition.
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Ophthalmic Surgical Instruments Market by Product (Cataracts (IOL, OVD), Refractive (Femtosecond, Excimer Laser) Glaucoma, Vitreoretinal (Vitrectomy Machine & Packs) Surgical Microscope] End User (Hospital, Specialty Clinic) - Global Forecast to 2022
The global ophthalmic surgical instruments market is expected to reach USD 11.18 Billion by 2022 from USD 7.87 Billion in 2016, at a CAGR of 6.0%. Growth in the global ophthalmic surgical instruments market is mainly driven by factors such as the increasing number of ophthalmic surgeries owing to the growth in geriatric population & related eye diseases, technological advancement in ophthalmic surgical devices, and government initiatives to increase the awareness about visual blindness across the globe. The prominent players in the ophthalmic surgical instruments market are Alcon (Switzerland), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Hoya Corporation (Japan), Bausch + Lomb (US), NIDEK (Japan), Topcon Corporation (Japan), Ellex Medical Lasers (Australia), IRIDEX Corporation (US), Lumenis (Israel), STAAR Surgical Company (US), and Ziemer Ophthalmic Systems (Switzerland).
- Published: November 2017
- Price: $ 4950
- TOC Available:
-
Medical Nitrous Oxide Market by Product (Gas, Liquid), Application (Anesthesia, Pain, Cryosurgery, Surgical Insufflation), End User (Hospital, Home healthcare, Academic, Research Institution), Key Stakeholder & Buying Criteria - Global Forecast to 2029
The global medical nitrous oxide market, valued at US$1.7 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2029, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The market is primarily driven by factors such as an increase in surgical procedures, a growing aging population, advancements in healthcare infrastructure, and growth in the dental industry.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Smart Hospital Market by Component (Hardware, Services, and Systems & Software), Services Rendered (General, Specialty, and Super Specialty), Connectivity, Application, Artificial Intelligence, and Region - Global Forecast to 2023
The smart hospital market was valued at USD 13.52 Billion in 2016 and is expected reach USD 63.49 Billion by 2023, at a CAGR of 24.00% from 2017 to 2023. The major players in the smart hospital market are Medtronic (Ireland), Philips (Netherlands), Microsoft (US), GE Healthcare (US) and Qualcomm Life (US), Honeywell Life Care Solutions (US), SAP (Germany), Allscripts (US), Allengers (India), Siemens AG (Germany), and CitiusTech Inc. (US), Infor (US), Athenahealth (US), PhysIQ (US), Diabetizer (Germany), AdhereTech (US), Epic (US), GlucoVista (US), STANLEY Healthcare (US), Cerner Corporation (US), and McKesson (US).
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Migraine Drugs Market by Product Type (Acute migraine treatment, Preventive migraine treatment), Route of administration (Oral, Injection, and Others), and End User (Hospital pharmacies, Retail pharmacies, Online pharmacies) - Global Forecast to 2023
The global Migrane Drugs market is expected to reach USD 3.96 billion by 2023 from USD 1.95 million in 2018, growing at a CAGR of 15.2%. Increasing awareness about novel therapies, launch of Calcitonin Gene-related Peptide (CGRP), increasing incidence of migraines and launch of new drugs are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new drugs, thus propelling the market growth.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
